isavuconazole and Long-QT-Syndrome

isavuconazole has been researched along with Long-QT-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for isavuconazole and Long-QT-Syndrome

ArticleYear
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:4

    A 22-year-old woman with cystic fibrosis developed QTc interval prolongation following lung transplantation in the setting of voriconazole therapy. After the discontinuation of voriconazole and initiation of isavuconazole, her QTc interval normalized. This case highlights the unique property of QTc interval shortening by isavuconazole among the triazole antifungals.

    Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult

2017